Q-omics provides the consensus-scored RPS12P24 profile across patient tissues and cancer cell-line models. RPS12P24 expression is associated with patient survival in 8 of 34 cancer types, with the highest sampling consensus in HNSC. Among the 18 cancer types available for tumor–normal comparison, RPS12P24 is differentially expressed in 4, with the highest sampling consensus in STAD. Additionally, RPS12P24 RNA expression shows 7,350 significant protein co-abundance associations, with the highest sampling consensus in PDAC. Together, these results highlight HNSC, STAD, and PDAC as cancer lineages where RPS12P24 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for RPS12P24 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes RPS12P24 survival associations across molecular data types. RPS12P24 RNA expression shows survival associations in the most cancer types (8). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible RPS12P24 RNA expression–survival associations across cancer types. High RPS12P24 expression shows unfavorable associations in HNSC, STAD, UVM, SARC, COAD and KIRC. The HNSC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify HNSC as the clearest survival context for RPS12P24 RNA expression.
This table summarizes RPS12P24 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 4. The strongest signals are observed in COAD for RNA.
This table ranks reproducible tumor–normal expression differences for RPS12P24. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. RPS12P24 shows lower tumor expression in STAD and KIRC and higher tumor expression in COAD and HNSC. The STAD box plot shows higher RPS12P24 RNA expression in normal versus tumor tissue (log2 FC = −0.066, t-test p = .034).
This table shows molecular features associated with RPS12P24 in patient tissues and cancer cell lines. In patient samples, RPS12P24 shows the broadest associations at the RNA and protein expression levels, with PDAC recurring as the lineage with the largest associated feature set.
